Detrimental Effect of Postoperative Complications on Oncologic Efficacy of R0 Pancreatectomy in Ductal Adenocarcinoma of the Pancreas

被引:27
|
作者
Kang, Chang Moo [1 ,2 ]
Kim, Dong Hyun [1 ,2 ]
Choi, Gi Hong [1 ,2 ]
Kim, Kyung Sik [1 ,2 ]
Choi, Jin Sub [1 ,2 ]
Lee, Woo Jung [1 ,2 ]
机构
[1] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea
[2] Yonsei Univ Hlth Syst, Inst Gastroenterol, Seoul, South Korea
关键词
Pancreatic cancer; Complication; R0; Pancreatectomy; Survival; LONG-TERM SURVIVAL; SINGLE-INSTITUTION EXPERIENCE; 1423; PANCREATICODUODENECTOMIES; RESECTABLE ADENOCARCINOMA; SURGEONS CONTRIBUTION; CURATIVE RESECTION; CANCER; HEAD; DETERMINANTS; CARCINOMA;
D O I
10.1007/s11605-009-0823-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Margin-negative resection of pancreatic cancers has proven to be the most effective treatment to date. Although there are frequent surgery-related complications following pancreatectomy, the oncologic effect of these complications following pancreatectomy for pancreatic cancer has not been studied. Retrospective observation of medical records of resected pancreatic ductal adenocarcinoma performed from January 1990 to June 2006 was used in this study. Potentially curative surgical resections of pancreatic ductal adenocarcinoma were performed on 103 patients. Survival was analyzed according to various clinicopathologic variables. Negative surgical margins (p = 0.0075) and absence of postoperative major complications related to surgery (p = 0.0116) were all significantly favorable prognostic factors in both univariate and multivariate analysis. Margin-negative pancreatectomy without major complications showed the most favorable oncologic outcomes in resected pancreatic cancer (median survival, 35.6 months; 95% confidential interval, 25.8-45.4 months), while major morbidities diminished survival benefit of R0 resection [R0-Cx(+), Exp(beta) = 1.925, p = 0.034, and R1, Exp(beta) = 3.129, p = 0.001]. Surgery-related major complication diminished the oncologic efficacy of R0 pancreatectomy. Margin-negative resection without major complication can enhance postoperative oncologic outcomes in ductal adenocarcinoma of the pancreas.
引用
收藏
页码:907 / 914
页数:8
相关论文
共 34 条
  • [31] Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9
    Dengfeng Li
    Qing Peng
    Leyao Wang
    Wei Cai
    Meng Liang
    Siyun Liu
    Xiaohong Ma
    Xinming Zhao
    European Radiology, 2024, 34 (1) : 509 - 524
  • [32] Reporting residual disease (R0/R1) following pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a joint position statement by the International Study Group for Pancreatic Surgery (ISGPS) and the International Study Group of Pancreatic Pathologists (ISGPP)
    Farina, A.
    Theijse, R.
    Janssen, B.
    Lutter, L.
    Basturk, O.
    Brosens, L.
    Esposito, I.
    Fukushima, N.
    Henriques, V.
    Luchini, C.
    Wang, H.
    Werner, J.
    Verbeke, C.
    Besselink, M.
    Adsay, V.
    VIRCHOWS ARCHIV, 2024, 485 : S28 - S28
  • [33] THE EFFECT OF TP ONE WEEK REGIMEN COMBINED WITH RADIOTHERAPY ON THE CLINICAL EFFICACY AND POSTOPERATIVE COMPLICATIONS OF STAGE III ESOPHAGEAL GASTRIC JUNCTION ADENOCARCINOMA
    Yu, Zihan
    Xiao, Jing
    Han, Ning
    Wei, Linlin
    Sun, Shichen
    Zhang, Yaotian
    ACTA MEDICA MEDITERRANEA, 2021, 37 (03): : 1383 - 1387
  • [34] Does pre-operative embolization of a replaced right hepatic artery before pancreaticoduodenectomy for pancreatic adenocarcinoma affect postoperative morbidity and R0 resection? A bi-centric French cohort study
    Marichez, Arthur
    Turrini, Olivier
    Fernandez, Benjamin
    Garnier, Jonathan
    Lapuyade, Bruno
    Ewald, Jacques
    Adam, Jean-Philippe
    Marchese, Ugo
    Chiche, Laurence
    Delpero, Jean-Robert
    Laurent, Christophe
    HPB, 2021, 23 (11) : 1683 - 1691